← Browse by Condition
Medical Condition
nasopharyngeal carcinoma npc
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 3
NCT06796270
Recruiting
Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma
Enrollment
24 pts
Location
China
Sponsor
The Second Affiliated Hospital...
NCT06839066 Phase 2
Recruiting
A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy
Enrollment
70 pts
Location
China
Sponsor
Shanghai Henlius Biotech
NCT07072143
Recruiting
An International Study on Pediatric Patients With Rare Tumors.
Enrollment
6,250 pts
Location
Italy
Sponsor
Azienda Ospedaliera di Padova
NCT07459296 Phase 3
Recruiting
Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
Enrollment
266 pts
Location
China
Sponsor
First Affiliated Hospital of G...
NCT06870435
Recruiting
Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas
Enrollment
68,649 pts
Location
China
Sponsor
Ming-Yuan Chen